Roosta and colleagues27 identified the clinical association of CD44 with the stage of breast cancer and systematic reviews and meta‐analyses revealed that CD44 expression is a prognostic factor for pharyngolaryngeal cancer,28 non‐small‐cell lung cancer,29 renal cell carcinoma30 and colorectal cancer.31 Here, CD44 is linked to breast carcinoma.